Sartorius Stedim Biotech expands PAT software portfolio
Adds Chemometrics software for Design of Experiments (DoE) and multivariate data analysis (MVA)
Sartorius Stedim Biotech (SSB), a pharmaceutical and biotech supplier, has entered into a global sales partnership with Umetrics, a Swedish software manufacturer. Umetrics supplies chemometrics software worldwide for modelling and optimising biopharmaceutical development and manufacturing processes.
Under the agreement SSB will assume global marketing and distribution of the complete Umetrics portfolio for the pharmaceutical and biopharmaceutical industries. The company will integrate Umetrics software programs as private label products into its own bioprocess portfolio and market them as stand-alone solutions under both brands.
Stefan Schlack, senior vice president of marketing at SSB, said: ‘These software solutions will help our customers to understand better their cell culture processes and to identify potential for optimisation and robust process control – an ideal addition to our bioprocess portfolio.’
Lars Lindstorm, general manager of Umetrics, added: ‘With SSB, we can gain access to substantially more customers thanks to its international reach and solid market standing in the biopharma sector. I anticipate that this will considerably boost the biopharmaceutical industry’s interest in and usage of our products.’
